Novo Nordisk joins forces with OpenAI to fast-track drug research

Danish pharma company Novo Nordisk has announced a partnership with OpenAI to apply artificial intelligence across its drug development process.…

Read the full article at the source

Just as Peter Parker never blindly trusted J. Jonah Jameson because he was Spider‑Man, remember that flashy announcements don’t replace due diligence.